4° Nordic CLL Meeting Copenhagen, September 11, 2008

First Page		Document Content
Laboratory techniques Molecular biology Polymerase chain reaction Leukemia Minimal residual disease Alemtuzumab B-cell chronic lymphocytic leukemia Biology Chemistry Science		4° Nordic CLL Meeting Copenhagen, September 11, 2008 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 825,71 KB Share Document on Facebook

	Lifebank_Logo_withTag-centered DocID: 1rakV - View Document
	Genome Informatics 15(2): 201–Kernel Mixture Survival Models for Identifying Cancer Subtypes, Predicting Patient’s Cancer Types DocID: 1qki5 - View Document
	Interim statement from the BCSH CLL Guidelines Panel George A Follows1, Adrian Bloor2, Claire Dearden3, Steve Devereux4, Christopher P Fox5, Peter Hillmen6, Ben Kennedy7, Helen McCarthy8, Nilima Parry-Jones9, Piers EM Pa DocID: 1qeKO - View Document
	PC-691-T100 Monoclonal Antibody to CD5 PerCP (100 tests) Clone: DocID: 1p8uO - View Document
	1P-482-T025 Monoclonal Antibody to CD5 Phycoerythrin (PE) conjugated (25 tests) Clone: DocID: 1oZDQ - View Document